Corcept Therapeutics Incorporated (CORT) Earnings Call Transcript & Summary

Good morning. Welcome to our annual meeting of Stockholders. I am Joe Belanoff, Corcept's Chief Executive Officer, I will act as chairman of this meeting. Charlie Robb, our Chief Business Officer will act as Secretary. The company hereby appoints Suzan Miller of CT Hagberg LLC to act as our inspector of elections. She will decide upon the qualifications of voters, accept their votes and count them. She's taken an oath to execute her duties with strict impartiality, which we will file with the records of the meeting. If you encounter technical difficulties, call our support team at 1 (844) 986-0822 in the United States or 1 (303) 562-9302 internationally. According to the inspector of election, we have received proxy votes for 102,368,830 of the 116,627,692 common shares outstanding on the record date, representing approximately 87.8% of our outstanding shares. Having received a quorum of votes, the meeting is called to order. We will vote today by proxy. If you have already voted, you don't need to vote again unless you want to change your vote. Those attending virtually can vote their proxy or change an earlier vote by clicking on the web portal's Voting button and following the instructions. Those attending in person who wish to vote or change an earlier vote should raise their hand, and we will give you a ballot so you can vote now. Each ballot must be signed by the stockholder voting or by his or her proxy and must state the number of shares voted. We will collect these ballots at the end of the meeting. Those who have already voted and do not wish to change their vote do not need to do anything. I will now describe the 2 matters to be voted on today. More detailed descriptions are in the proxy statement. The first item is the election of directors. Each director elected today will serve until our 2022 stockholders meeting. Our Board of Directors has nominated Gregg Alton, Len Baker, Gillian Cannon, David Mahoney, Kimberly Park, Dan Swisher, Jim Wilson and me. The proxy statement has more information about each nominee. The second item is ratification of the Board's appointment of Ernst & Young LLP as our independent auditors for 2021. Ernst & Young is represented at this meeting by Fran Schulz. We'll now pause -- we'll now take a brief pause to allow everyone time to vote. [Voting]

Everyone having had ample time to vote, the polls are closed, the inspector of election will now report the preliminary results.

The preliminary voting results are as follows: Proposal 1, all of the nominees for Director have received a plurality of votes as needed to be elected. Proposal #2, Ernst & Young has been ratified as the independent auditor for 2021.

There is no other business to conduct. The meeting is now closed. We will include the inspector of election's final report in the record of this meeting. We will include the final voting results in a Form 8-K filed with the SEC. There being no other business, the meeting is closed. Stockholders attending virtually may ask questions in the designated field on the web portal. Please limit yourself to one question. We will attempt to answer your main questions promptly after the meeting. Thank you.